## STZ: Constellation Brands, Inc. - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_20 4.0% below STRENGTH zone (4.0-10.0%); PEG 1.58 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($135.87)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Shareholders That Lost Money on Constellation Brands, Inc. (STZ) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More**
- Source: KSN-TV | 20251206T040826 | Neutral | Relevance: 98%
-  Levi & Korsinsky LLP is urging shareholders of Constellation Brands, Inc. (NYSE:STZ) who experienced losses between April 11, 2024, and January 8, 2025, to join a class action lawsuit. The lawsuit alleges securities fraud, citing a significant miss in the company's Q3 fiscal year 2025 sales performance for both the Beer and Wine & Spirits segments. This news led to a dramatic drop in Constellation's stock price.

**2. Shareholders That Lost Money on Constellation Brands, Inc.(STZ) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More**
- Source: MyHighPlains.com | 20251207T150927 | Neutral | Relevance: 98%
-  Levi & Korsinsky, LLP is urging shareholders of Constellation Brands, Inc. (NYSE:STZ) who suffered losses between April 11, 2024, and January 8, 2025, to join a class action lawsuit. The lawsuit alleges securities fraud, citing a significant miss in the company's Beer segment sales and an even steeper miss in Wine & Spirits, which led to a dramatic decline in stock price. Shareholders are encouraged to contact the firm to learn about potential recovery.

**3. Carlyle Group Inc. $CG Shares Sold by Beutel Goodman & Co Ltd.**
- Source: MarketBeat | 20251206T054038 | Neutral | Relevance: 66%
-  Beutel Goodman & Co. Ltd. reduced its stake in Carlyle Group Inc. (NASDAQ:CG) by 2.9% in the second quarter, selling 81,569 shares but still owning 2,771,630 shares valued at approximately $142.5 million. Carlyle Group met EPS estimates with $0.98 but missed revenue at $782.5 million against an expected $848.5 million. The company has a consensus "Hold" rating from analysts with a target price of $66.00 and offers an annual dividend yield of about 2.5%.

**4. THE KINGDOM OF BROWN GOODS: WHY MGPI IS BEING CRUSHED BY INVENTORY & PRIMED FOR RESURRECTION**
- Source: Simply Wall Street | 20251207T043326 | Somewhat-Bullish | Relevance: 64%
-  MGP Ingredients (MGPI) has seen its stock price decline by 73% in two years, primarily due to an inventory correction in the brown goods (bulk distilled spirits) market, which the market has mistakenly priced as a structural decline. Despite this, MGPI maintains a strong balance sheet, positive operating cash flow, and possesses three accelerating growth engines: Penelope Bourbon, El Mayor Tequila, and its Ingredient Solutions segment. The article argues that MGPI is undervalued and positioned for a significant recovery through P/B revaluation, EBITDA multiple expansion, and potential consolidation opportunities as competitors face financial distress.

**5. MGP Ingredients, Inc.'s (NASDAQ:MGPI) Price Is Right But Growth Is Lacking**
- Source: Simply Wall Street | 20251207T043326 | Neutral | Relevance: 63%
-  MGP Ingredients, Inc. currently has a low price-to-sales (P/S) ratio of 0.9x, suggesting it might be undervalued compared to the broader Beverage industry. However, this low P/S ratio is attributed to MGP Ingredients' declining revenue, which has fallen by 22% in the last year and 24% over the past three years. Analysts forecast further revenue decline of 10% over the next year, contrasting with the industry's expected 5.0% growth, making the low P/S ratio understandable.

### Analyst Activity

**Target Signal:** BEARISH (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-21 | Piper Sandler | $135 | $155 | -13% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-21 | Piper Sandler | main | Neutral |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 44.0% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 3 / 6 |

**Top Holders:**
- Vanguard Group Inc: 10.5% (+3.2%)
- Berkshire Hathaway, : 7.7% (0.0%)
- Blackrock Inc.: 6.1% (-2.0%)
- Capital World Invest: 3.8% (-43.3%)
- State Street Corpora: 3.8% (-4.2%)

### Key Risks

1. Long-term trend broken: trading 12.6% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.58 elevated, pricing in significant growth expectations. Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bearish (6 selling vs 3 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $24.7B |
| Beta | 0.46 |
| 52W Range | $126.45 - $245.31 |
| Short Interest | 5.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.58 |
| Forward P/E | 11.4 |
| Current P/E | 12.4 |
| YoY Growth | 8.0% |
| EPS Direction | FALLING |

### Technicals

MRS_20 improving modestly (+1.0% over 5 days). Below STRENGTH zone by 0.0pp (needs >4.0% for momentum thesis). MRS_5 at 1.5% confirms short-term momentum alignment. AM_20 at 6.1% shows strong absolute momentum above own 20MA. Outperforming sector by 6.0pp, stock-specific strength. Below SMA200 (0.87x), long-term trend not supportive. MACD histogram positive (1.37), confirming momentum.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 3.98% (CS: 81) | Neutral |
| RSI_14 | 68.0 | Neutral |
| MACD Histogram | 1.37 | Bullish |
| vs SMA20 | 1.061x | Above |
| vs SMA50 | 1.046x | Above |
| vs SMA200 | 0.874x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $141.99
- **Stop Loss:** $135.87 (4.3% risk)
- **Target:** $148.11 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 81
- **Position Value:** $11,501.19
- **Portfolio %:** 11.50%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

### Earnings

**Next:** 2026-01-07 (Est: $2.65)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.41 | $3.63 | +6.5% |
| 2025Q2 | $3.29 | $3.22 | -2.3% |
| 2025Q1 | $2.27 | $2.63 | +15.9% |
| 2024Q4 | $3.31 | $3.25 | -1.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*